DBJ Invests in Emergent Medical Partners II, L.P.,An Investment Fund for Leading-edge Medical Devices in Silicon Valley

Development Bank of Japan Inc. (Toru Hashimoto, President & CEO) announces its investment in Emergent Medical Partners II, L.P., a U.S. investment fund that focuses on leading-edge medical devices.

Fostering the growth and soundness of healthcare industries is gaining in importance as Japan evolves into a “super-aged” society. In the report Silicon Valley's “Ecosystem” for the Development of Medical Devices: What are Its Lessons for Japan?, published in September 2013, DBJ examined the “ecosystem” in the United States that promotes the transformation of ideas into marketable products, and found it was a major reason for the country’s success in developing medical devices.

Emergent Medical Partners II was founded by Dr. Thomas Fogarty, a world-renowned innovator and entrepreneur with long experience in the region. By using its Fund for Japanese Industrial Competitiveness to supply Emergent Medical Partners II with risk money, DBJ hopes to forge a connection between Japanese industry and the medical device “ecosystem” in Silicon Valley. The bulk of the fund’s joint investors are Japanese firms, including Terumo Corporation.

The knowledge gained through this initiative can prove of immense benefit to Japanese industries and communities while creating new value for the nation’s medical device manufacturers. DBJ’s support will help the industry to grow and enjoy greater competitiveness on the global stage.


Inquiries:
Corporate Finance Department, Division 6; Healthcare Office
Telephone: 81-3-3244-1730